Management of ruptured brain arteriovenous malformations

Current Atherosclerosis Reports

Volumn 14, Issue 4, 2012, Pages 335-342

  Zacharia, Brad E ^a   Vaughan, Kerry A ^a   Jacoby, Adam ^a   Hickman, Zachary L ^a   Bodmer, Daniel ^a   Connolly Jr , E Sander ^a  

^a Columbia University ^*  (United States)

Author keywords

Arteriovenous malformation; AVM; Intracerebral hemorrhage; Ruptured AVM

Indexed keywords

ALTEPLASE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO;

AGE DISTRIBUTION; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN RADIOGRAPHY; CAVERNOUS SINUS THROMBOSIS; CEREBRAL SINUS THROMBOSIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSCIOUSNESS DISORDER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; HEADACHE; HUMAN; INTRACRANIAL HYPERTENSION; MECHANICAL THROMBECTOMY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PAPILLEDEMA; PHLEBOGRAPHY; RISK ASSESSMENT; SEIZURE; SEX DIFFERENCE;

ANTIHYPERTENSIVE AGENTS; ARTERIOVENOUS FISTULA; CEREBRAL HEMORRHAGE; COAGULANTS; EMBOLIZATION, THERAPEUTIC; ENDOVASCULAR PROCEDURES; HUMANS; INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; NEUROSURGICAL PROCEDURES; RADIOSURGERY; RUPTURE, SPONTANEOUS;

EID: 84865606057     PISSN: 15233804     EISSN: 15346242     Source Type: Journal    
DOI: 10.1007/s11883-012-0257-9     Document Type: Article

References (44)

1. Friedlander RM Clinical practice. Arteriovenous malformations of the brain. N Engl J Med. 2007;356(26):2704-12. (Pubitemid 47001039)
2. Laakso A, Hernesniemi J. Arteriovenous malformations: epidemiology and clinical presentation. Neurosurg Clin N Am. 2012;23 (1):1-6.
3. Steiger H-J, Schmid-Elsaesser R, Muacevic A (2002) Neurosurgery of arteriovenous malformations and fistulas. 473
4. Ogilvy CS, Stieg PE, Awad I, Brown RD, Kondziolka D, Rosenwasser R, Young WL, Hademenos G, Special Writing Group of the Stroke Council, American Stroke Association. AHA scientific statement: recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. Stroke. 2001;32(6):1458-71. (Pubitemid 32530442)
5. Aoun SG, Bendok BR, Batjer HH. Acute management of ruptured arteriovenous malformations and dural arteriovenous fistulas. Neurosurg Clin N Am. 2012;23(1):87-103. This article provides an up-To-date, concise review of all relevant studies on the acute management of ruptured lesions.
6. Al-Shahi R, Warlow C. A systematic review of the frequency and prognosis of arteriovenous malformations of the brain in adults. Brain. 2001;124(Pt 10):1900-26. (Pubitemid 32951757)
7. Barr JC, Ogilvy CS. Selection of treatment modalities or observation of arteriovenous malformations. Neurosurg Clin N Am. 2012;23(1):63-75. This article presents concise, evidence-based observations and guidelines for appropriate selection of treatment options for arteriovenous malformations.
8. van Beijnum J, van der Worp HB, Buis DR, Al-Shahi Salman R, Kappelle LJ, Rinkel GJE, van der Sprenkel JWB, Vandertop WP, Algra A, Klijn CJM Treatment of brain arteriovenous malformations: a systematic review and meta-Analysis. JAMA. 2011;306 (18):2011-9. This review provides a comprehensive understanding of global trends and paradigms in the permanent treatment of arteriovenous malformations.
9. Mandybur TI, Nazek M Cerebral arteriovenous malformations. A detailed morphological and immunohistochemical study using actin. Arch Pathol Lab Med. 1990;114(9):970-3. (Pubitemid 20265295)
10. Moftakhar P, Hauptman JS, Malkasian D, Martin NA. Cerebral arteriovenous malformations. Part 2: physiology. Neurosurg Focus. 2009;26(5):E11.
11. Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg. 58(3):331-7.
12. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw AV, Connolly ES, Pile-Spellman J, Mohr JP. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350-5. (Pubitemid 43739643)
13. Mast H, Young WL, Koennecke HC, Sciacca RR, Osipov A, Pile-Spellman J, Hacein-Bey L, Duong H, Stein BM, Mohr JP. Risk of spontaneous haemorrhage after diagnosis of cerebral arteriovenous malformation. Lancet. 1997;350(9084):1065-8. (Pubitemid 27437857)
14. Forster DM, Steiner L, Håkanson S. Arteriovenous malformations of the brain. A long-Term clinical study. J Neurosurg. 1972;37 (5):562-70.
15. van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJM, Al-Shahi Salman R, on behalf of the SIVMS Steering Committee and the Oxford Vascular Study. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: population-based studies. Brain. 2008;132(2):537-43.
16. Diringer MN. Intracerebral hemorrhage: pathophysiology and management. Crit Care Med. 1993;21(10):1591-603. (Pubitemid 23312498)
17. Abdullah AR, Smith EE, Biddinger PD, Kalenderian D, Schwamm LH. Advance hospital notification by EMS in acute stroke is associated with shorter door-To-computed tomography time and increased likelihood of administration of tissue-plasminogen activator. Prehosp Emerg Care. 2008;12(4):426-31.
18. Morgenstern LB, Hemphill JC, Anderson C, et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2010;41 (9):2108-29.
19. Diringer MN, Edwards DF. Admission to a neurologic/neurosurgical intensive care unit is associated with reduced mortality rate after intracerebral hemorrhage. Crit Care Med. 2001;29(3):635-40. (Pubitemid 32225309)
20. Broderick J, Connolly S, Feldmann E, et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American Stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Circulation. 2007;116 (16):e391-413.
21. Schutz H, Bodeker R, Damian M, Krack P, Dorndorf W. Agerelated spontaneous intracerebral hematoma in a German community. Stroke. 1990;21:1412-8. (Pubitemid 20339708)
22. Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD, Cushman M Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007;38(10):2718-25. (Pubitemid 47494009)
23. Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF. Spontaneous intracerebral hemorrhage. N Engl J Med. 2001;344(19):1450-60. (Pubitemid 32402103)
24. Nüssel F,Wegmüller H, Huber P. Comparison ofmagnetic resonance angiography, magnetic resonance imaging and conventional angiography in cerebral arteriovenous malformation. Neuroradiology. ;33(1):56-61.
25. Anzalone N, Scomazzoni F, Strada L, Patay Z, Scotti G. Intracranial vascular malformations. Eur Radiol. 1998;8(5):685-90. (Pubitemid 128662624)
26. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, Skolnick BE, Steiner T, FAST trial investigators. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med. 2008;358 (20):2127-37. (Pubitemid 351679599)
27. Adeoye O, Broderick JP. Advances in the management of intracerebral hemorrhage. Nat Rev Neurol. 2010;6(11):593-601. This article eloquently summarizes relevant literature on advances in treatments for intracerebral hemorrhage and provides an important framework for future adoption of new treatment options.
28. Zhang Y, Reilly KH, Tong W, Xu T, Chen J, Bazzano LA, Qiao D, Ju Z, Chen C-S, He J. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens. 2008;26(7):1446-52.
29. Anderson CS, Huang Y, Arima H, et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the Intensive Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial (INTERACT). Stroke. 2010;41(2):307-12.
30. Qureshi AI, Palesch YY. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocritical care. 2011. doi:10.1007/s12028-011-9538-3.
31. Fogelholm R, Murros K, Rissanen A, Avikainen S. Admission blood glucose and short term survival in primary intracerebral haemorrhage: a population based study. J Neurol Neurosurg Psychiatr. 2005;76(3):349-53. (Pubitemid 40299122)
32. Schwarz S, Häfner K, Aschoff A, Schwab S. Incidence and prognostic significance of fever following intracerebral hemorrhage. Neurology. 2000;54(2):354-61. (Pubitemid 30078066)
33. Kollmar R, Juettler E, Huttner HB, Dörfler A, Staykov D, Kallmuenzer B, Schmutzhard E, Schwab S, Broessner G, for the CINCH investigators. Cooling in intracerebral hemorrhage (CINCH) trial: protocol of a randomized German-Austrian clinical trial. Int J Stroke. 2012;7(2):168-72.
34. Bladin CF, Alexandrov AV, Bellavance A, Bornstein N, Chambers B, Coté R, Lebrun L, Pirisi A, Norris JW. Seizures after stroke: a prospective multicenter study. Arch Neurol. 2000;57(11):1617-22.
35. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg. 1986;65(4):476-83. (Pubitemid 16000693)
36. Kuhmonen J, Piippo A, Väärt K, Karatas A, Ishii K, Winkler P, Niemelä M, Porras M, Hernesniemi J. Early surgery for ruptured cerebral arteriovenous malformations. Acta Neurochir Suppl. 2005;94:111-4.
37. Brown RD. Simple risk predictions for arteriovenous malformation hemorrhage. Neurosurgery. 2000;46(4):1024.
38. Mohr JP, Moskowitz AJ, Stapf C, et al. The ARUBA trial: current status, future hopes. Stroke. 2010;41(8):e537-40.
39. Brown RD, Flemming KD, Meyer FB, Cloft HJ, Pollock BE, Link ML. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc. 2005;80(2):269-81. (Pubitemid 40194542)
40. Hartmann A, Pile-Spellman J, Stapf C, Sciacca RR, Faulstich A, Mohr JP, Schumacher HC, Mast H. Risk of endovascular treatment of brain arteriovenous malformations. Stroke. 2002;33(7):1816-20. (Pubitemid 34761067)
41. Pikus HJ, Beach ML, Harbaugh RE. Microsurgical treatment of arteriovenous malformations: analysis and comparison with stereotactic radiosurgery. J Neurosurg. 1998;88(4):641-6. (Pubitemid 28145205)
42. Maruyama K, Kondziolka D, Niranjan A, Flickinger JC, Lunsford LD. Stereotactic radiosurgery for brainstem arteriovenous malformations: factors affecting outcome. J Neurosurg. 2004;100 (3):407-13. (Pubitemid 38269067)
43. Maruyama K, Koga T, Shin M, Igaki H, Tago M, Saito N. Optimal timing for Gamma Knife surgery after hemorrhage from brain arteriovenous malformations. J Neurosurg. 2008;109(Suppl):73-6.
44. Maruyama K, Kawahara N, Shin M, Tago M, Kishimoto J, Kurita H, Kawamoto S, Morita A, Kirino T. The risk of hemorrhage after radiosurgery for cerebral arteriovenous malformations. N Engl J Med. 2005;352(2):146-53. (Pubitemid 40096611)